drugset / Trial / NCT02906553
The Role of Nitric Oxide in Cognition in Schizophrenia
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study evaluates the role of the Nitric Oxide system in cognition in patients with schizophrenia. Participants will be randomised to 2 equal groups and receive either the Nitric Oxide donor molecule glyceryl trinitrate, or a placebo. Performance on several cognitive tasks will be assessed.
Timeline
- Start
- 2016-09
- Primary completion
- 2019-04
- Completion
- 2019-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitroglycerin | Unknown | 0.4 mg | Other |